Exosome Diagnostics Obtains $27,000,000 Series B Funding Round

  • Feed Type
  • Date
    3/11/2014
  • Company Name
    Exosome Diagnostics
  • Mailing Address
    3960 Broadway New York, NY 10032
  • Company Description
    Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids.
  • Website
    http://www.exosomedx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $27,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds will be used to advance development of the Company’s proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.
  • M&A Terms
  • Venture Investor
    QIAGEN
  • Venture Investor
    Arcus Ventures
  • Venture Investor
    Tiger Global Management
  • Venture Investor
    CD Ventures
  • Venture Investor
    Monashees Capital
  • Venture Investor
    NGN Capital
  • Venture Investor
    Forbion Capital Partners

By posting a comment, you agree to our terms and conditions.